Hello from GCCL (Global Clinical Central Lab)!
We are excited to announce that GCCL will be participating in the BIO International Convention 2025,
the world’s largest biotechnology event, held from June 16 to 19, 2025 at the Boston Convention & Exhibition Center.
Meet the GCCL Partnering Team at BIO USA 2025
💊 KwanGoo Cho, CEO
📣 Yuwha Choi, COO
👩💼 Sandra Woo, Team Leader, Global Business Development
With participation from over 1,000 biotech companies and organizations from more than 60 countries,
the BIO USA is a premier global partnering event. GCCL will leverage this opportunity to highlight our position as the largest Central Lab in Asia and enhance our global visibility.
We aim to connect with global pharmaceutical companies, biotechs, and CROs to explore opportunities for collaboration as a trusted bioanalytical partner throughout the drug development journey.
Our key strengths include:
✅ Quality assurance system based on GCLP, CAP, and ISO15189 certifications
✅ Specialized platforms for Oncology, Infectious Diseases, and Cell & Gene Therapy (CGT)
✅ Advanced infrastructure including LIMS and ddPCR systems
✅ Analytical capabilities as an APAC Central Lab with a strong global network
For partnering or collaboration inquiries, feel free to contact us at:
We look forward to meeting you at BIO USA 2025 as your trusted global partner for end-to-end clinical trial sample analysis.
GCCL is committed to being your most reliable clinical trial partner, delivering value and trust across every project.
Click the banners below to learn more about GCCL.
> About GCCL > Newsroom > Company News